MBChB, FRACP, FRCPA, Spec Cert in Clinical Research (Oncology) Associate Professor Judith Trotman is the Director of the Clinical Research Unit at Concord Hospital, Sydney where she has built a broad portfolio of trials across the spectrum of haematologic malignancies, accessing emerging new therapies for patients from across New South Wales, Australia. She has particular expertise in the management of lymphoid malignancies. Committed to local and international collaboration in investigator initiated research she is a member of the Australasian Leukaemia Lymphoma Group (ALLG) Scientific Advisory Committee and the ALLG Principal Investigator for five lymphoma studies: REMARC, RATHL, IRiC, RePLY, and a PET project where she led European researchers in demonstrating the predictive power of PET imaging in follicular lymphoma (JCO and Lancet Haematology). The RATHL study was recently published in NEJM June 2016. She is an author of the recent 2014 international guidelines in staging and response assessment of Lymphoma (JCO). She and Roslyn Ristuccia were awarded the 2015 Premier’s Award for Outstanding Cancer Research - Innovation in Clinical Trials, as co-inventor of ClinTrial Refer – an innovative cross-referral smart-phone App that is facilitating patient access to clinical trials across Australia.